Business & Entrepreneurship

Alumnus Vijay Shroff’s background as an attorney helps him prioritize community and collaboration in business.

In her business and engagement with WashU, Lynn Gorguze prioritizes relationships and building community.

On-campus leadership opportunities put Christina Walker on a path to help future student-athletes thrive.

Public health scholar and entrepreneur Joseph T. Steensma bridges research and real-world impact, translating science into scalable solutions that address environmental and population health challenges.

WashU Olin Business School will host its annual spring symposium, aimed at improving health outcomes. The daylong event offers participants business-driven perspectives on health and the chance to connect with peers from WashU and beyond.

Four WashU researchers have been named senior members of the National Academy of Inventors: Rajan Chakrabarty, Vijay Ramani, Christina Stallings and Zhude Tu.

WashU has been named to the National Academy of Inventors’ Top 100 Worldwide Universities granted U.S. utility patents in 2025. The university is ranked 49 on the list, with 70 total patents.

High prescription drug prices are not caused by any single company or practice, but by the system itself, said WashU Law’s Rachel Sachs. If Congress wants lower drug prices, it has to fix the structure and incentives of the entire supply chain, said Sachs, an expert on prescription drug pricing.

Jeffrey Plunkett, a professor of practice in accounting at WashU Olin Business School, answers common questions about new tax rules, how changes in Internal Revenue System staffing could impact the filing process and who needs an accountant.

As WashU’s vice chancellor for innovation and commercialization, Doug Frantz helps speed scientific discoveries into real-world therapies and devices. He works to develop strategic partnerships with industry and enhance WashU’s commercialization efforts.